JUL 29, 2019 12:12 PM PDT

Compound Found in Wine May Treat Anxiety

WRITTEN BY: Nouran Amin

A study published in the journal Neuropharmacology claims that a compound found in red wine could be used as therapeutic for treating anxiety and depression disorders. The compound, called resveratrol, was seen too be involved in anti-stress effects by blocking the expression of an enzyme implicate din stress control of the brain. The study brings new light to how resveratrol is implicated in neurological processes and lays the ground work for future novel antidepressants that re safe and effective.

"Resveratrol may be an effective alternative to drugs for treating patients suffering from depression and anxiety disorders," says Ying Xu, MD, PhD, co-lead author and research associate professor in the UB School of Pharmacy and Pharmaceutical Sciences.

Resveratrol is plant-based and found in the skin and seeds of grapes and berries. Resveratrol has been known to be linked to multiple health benefits including neuroprotection. Recently, research has identified resveratrol’s main mechanism of action by targeting an enzyme known as phosphodiesterase 4 (PDE4)—which is influenced by the stress hormone corticosterone that regulates stress levels. When resveratrol targets PDE4 through inhibiting its actions, it brings antidepressant effects.

“These unknown physiological relationships make drug therapy complex. Current antidepressants instead focus on serotonin or noradrenaline function in the brain, but only one-third of patients with depression enter full remission in response to these medications,” says Xu.

Corticosterone induces excessive amounts of PDE4 in stressed mice and results in depression and anxiety-like behavior. PDE4 is known to reduce cyclic adenosine monophosphate -- a messenger molecule involved in signaling cellular physiological changes such as cell division, change, migration and death. These changes lead to physical alterations in the brain that such disorders begin to develop.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
OCT 23, 2020
Drug Discovery & Development
FDA Gives Full Approval to Remdesivir to Treat COVID-19
OCT 23, 2020
FDA Gives Full Approval to Remdesivir to Treat COVID-19
The US Food and Drug Administration (FDA) has approved antiviral drug Remdesivir, sold under the name ‘Velkury&rsq ...
OCT 03, 2020
Drug Discovery & Development
Treating Gut-Leakiness
OCT 03, 2020
Treating Gut-Leakiness
A drug called tofacitinib, also called Xeljanz , was found to treat permeability defects in the intestines. Tofacitinib ...
NOV 01, 2020
Cannabis Sciences
Can Cannabis Treat ALS?
NOV 01, 2020
Can Cannabis Treat ALS?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative illness that damages motor neurons and leads to progressive m ...
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 25, 2020
Drug Discovery & Development
Improving Drug Dissolution
NOV 25, 2020
Improving Drug Dissolution
When you take your medicine, it travels through the bloodstream and releases its effects. When the drug dissolves too fa ...
Loading Comments...